Specific Renal Uptake of Randomly 50% N-Acetylated Low Molecular Weight Chitosan-Reference-Cited by-同舟云学术

Specific Renal Uptake of Randomly 50% N-Acetylated Low Molecular Weight Chitosan

Published:2008-11-26 Issue:1 Volume:6 Page:305-314
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Yuan Zhi-xiang¹,Zhang Zhi-rong¹,Zhu Di¹,Sun Xun¹,Gong Tao¹,Liu Jie¹,Luan Chang-tao¹

Affiliation:

1. Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, People’s Republic of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp800078a

Reference48 articles.

1. Megalin Deficiency Offers Protection from Renal Aminoglycoside Accumulation

2. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs.

3. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance.

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal-Targeted Drug Delivery by Chitosan Oligosaccharide Micelles with HSA-Enriched Protein Corona for the Treatment of Ischemia/Reperfusion-Induced Acute Kidney Injury;ACS Applied Materials & Interfaces;2024-09-06

2. Exploring the Synergistic Potential of Pectin-Chitosan Composites for Advanced Drug Delivery and Biomedical Implant Applications: A Comprehensive Review and Future Perspectives;F1000Research;2024-09-04

3. Exploring the Synergistic Potential of Pectin-Chitosan Composites for Advanced Drug Delivery and Biomedical Implant Applications: A Comprehensive Review and Future Perspectives;F1000Research;2024-03-21

4. DESIGN AND OPTIMIZATION OF NANO ENCAPSULATED BIO COMPOUNDS OF ASPARAGUS RACEMOSUS: BOX BEHNKEN APPROACH;International Journal of Applied Pharmaceutics;2024-01-07

5. Chitosan-based oral nanoparticles as an efficient platform for kidney-targeted drug delivery in the treatment of renal fibrosis;International Journal of Biological Macromolecules;2024-01